Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CTKB is expected to report earnings to fall 87.50% to 0 cents per share on November 11
Q3'25
Est.
$0.00
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.01
The last earnings report on August 06 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 317.06K shares outstanding, the current market capitalization sits at 506.35M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTKB showed earnings on August 06, 2025. You can read more about the earnings report here.